NMD Pharma A/S — Credit Rating and Financial Key Figures
CVR number: 36899069
Palle Juul-Jensens Boulevard 82, 8200 Aarhus N
Income statement (kEUR)
| 2017 | 2018 | |
|---|---|---|
| Fiscal period length | 12 | 12 |
| Net sales | ||
| Gross profit | -2 391.51 | -4 661.85 |
| Employee benefit expenses | -1 039.54 | -1 508.11 |
| EBIT | -3 431.05 | -6 169.95 |
| Other financial income | 6.86 | |
| Other financial expenses | - 165.37 | - 109.43 |
| Pre-tax profit | -3 589.56 | -6 279.39 |
| Income taxes | 658.93 | 736.56 |
| Net earnings | -2 930.63 | -5 542.83 |
Assets (kEUR)
| 2017 | 2018 | |
|---|---|---|
| Intangible assets total | ||
| Tangible assets total | ||
| Investments total | ||
| Long term receivables total | ||
| Inventories total | ||
| Prepayments and accrued income | 11.54 | 19.02 |
| Current other receivables | 77.02 | 138.91 |
| Current deferred tax assets | 658.93 | 736.56 |
| Short term receivables total | 747.49 | 894.49 |
| Cash and bank deposits | 2 096.43 | 5 847.90 |
| Cash and cash equivalents | 2 096.43 | 5 847.90 |
| Balance sheet total (assets) | 2 843.93 | 6 742.39 |
Equity and liabilities (kEUR)
| 2017 | 2018 | |
|---|---|---|
| Share capital | 23.44 | 87.55 |
| Retained earnings | 1 737.59 | 11 202.39 |
| Profit of the financial year | -2 930.63 | -5 542.83 |
| Shareholders equity total | -1 169.60 | 5 747.10 |
| Non-current liabilities total | ||
| Current loans from credit institutions | 3 433.71 | |
| Current trade creditors | 344.26 | 780.20 |
| Other non-interest bearing current liabilities | 235.55 | 215.08 |
| Current liabilities total | 4 013.53 | 995.28 |
| Balance sheet total (liabilities) | 2 843.93 | 6 742.39 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.